Investors
IR News
Strategy
Analysts
Corporate Governance
Shareholder FAQs
Annual Report
Alerts Service
Latest Presentations
Webcast
Investors
/ IR News
Search for:
Type:
Any Topic
Directors Shareholding
Holdings in Company
Results
Board Changes
Regulatory
Clinical Trials
Other
From:
All
2010
2009
2008
2007
2006
2005
2004
2003
2002
INVESTOR RELATIONS NEWS
30 March 2010
Exercise of Options
29 March 2010
EU Phase III trial for Juvista is fully recruited
24 March 2010
Holding(s) in Company
18 March 2010
Holding(s) in Company
15 March 2010
Blocklisting application
02 March 2010
Holding(s) in Company
02 March 2010
Revised Shire licensing deal for Juvista
17 February 2010
Holding(s) in Company
11 February 2010
Holding(s) in Company
10 February 2010
Company AGM
Results Pages
<<
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
>>
PRODUCT PIPELINE
Juvista - Scar Reduction in skin
Adaprev – Scar reduction in tendons
Prevascar - Reduced Scarring
Juvidex - Improved skin appearance
RN1005 - for reduction of scarring
SHARE PRICE
Data supplied by AXL Performance Solutions - http://www.axl.co.uk
ABOUT US
|
PRODUCTS
|
RESEARCH & DEVELOPMENT
|
PARTNERS
|
MEDIA
|
INVESTORS
|
CAREERS
|
VOLUNTEERS
privacy policy
